The transition from mild to moderate-to-severe chronic plaque psoriasis

被引：0
|
作者：
Bellinato, Francesco [1 ,3 ]
Gisondi, Paolo [1 ]
Mioso, Guido [2 ]
Mason, Elena [1 ]
Straiotto, Danny [2 ]
Piaserico, Stefano [2 ]
Girolomoni, Giampiero [1 ]
机构：
[1] Univ Verona, Dept Med, Sect Dermatol & Venereol, Verona, Italy
[2] Univ Padua, Dept Med, Sect Dermatol, Padua, Italy
[3] Univ Verona, Dept Med, Sect Dermatol & Venereol, Piazzale A Stefani 1, I-37126 Verona, Italy
来源：
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY | 2023年 / 37卷 / 10期
关键词：
LATE-ONSET;
D O I：
10.1111/jdv.19208
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：E1215 / E1217
页数：3
相关论文
共 50 条
  • [1] The management of moderate-to-severe chronic plaque psoriasis
    Tonini, Annalisa
    Panduri, Salvatore
    D'Erme, Angelo M.
    Papadia, Francesca
    Romaneli, Marco
    Krueger, James G.
    Chiricozzi, Andrea
    GIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA, 2017, 152 (05): : 447 - 457
  • [2] Apremilast in the therapy of moderate-to-severe chronic plaque psoriasis
    Gisondi, Paolo
    Girolomoni, Giampiero
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2016, 10 : 1763 - 1770
  • [3] Risankizumab in moderate-to-severe plaque psoriasis
    Serrano, Linda
    Maloney, Victoria
    Gordon, Kenneth B.
    IMMUNOTHERAPY, 2019, 11 (16) : 1357 - 1370
  • [4] Methotrexate versus cyclosporine in moderate-to-severe chronic plaque psoriasis
    Heydendael, VMR
    Spuls, PI
    Opmeer, BC
    de Borgie, CAJM
    Reitsma, JB
    Goldschmidt, WFM
    Bossuyt, PMM
    Bos, JD
    de Rie, MA
    NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (07): : 658 - 665
  • [5] Predictors of response to tildrakizumab for moderate-to-severe chronic plaque psoriasis
    Blauvelt, Andrew
    Reich, Kristian
    Papp, Kim A.
    Tyring, Stephen K.
    Sinclair, Rodney
    Thaci, Diamant
    Gooderham, Melinda
    Li, Qing
    Cichanowitz, Nicole
    la Rosa, Carmen
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 79 (03) : AB226 - AB226
  • [6] Treatment of moderate-to-severe plaque psoriasis
    Salgo, R.
    Thaci, D.
    GIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA, 2009, 144 (06): : 701 - 711
  • [7] Tildrakizumab for Moderate-to-Severe Chronic Plaque Psoriasis: a Review of the Literature
    Kory P. Schrom
    Avi Bitterman
    Neil J. Korman
    Current Dermatology Reports, 2019, 8 : 6 - 13
  • [8] Tildrakizumab for Moderate-to-Severe Chronic Plaque Psoriasis: a Review of the Literature
    Schrom, Kory P.
    Bitterman, Avi
    Korman, Neil J.
    CURRENT DERMATOLOGY REPORTS, 2019, 8 (01) : 6 - 13
  • [9] Ustekinumab: Treatment of Adult Moderate-to-Severe Chronic Plaque Psoriasis
    Scanlon, James V.
    Exter, Benjamin P.
    Steinberg, Michael
    Jarvis, Courtney I.
    ANNALS OF PHARMACOTHERAPY, 2009, 43 (09) : 1456 - 1465
  • [10] Tildrakizumab: A Review in Moderate-to-Severe Plaque Psoriasis
    Frampton, James E.
    AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2019, 20 (02) : 295 - 306
12345